June 29, 2016, IBA -- IBA (Ion Beam Applications S.A., EURONEXT), the world’s leading provider of proton therapy solutions for the treatment of cancer, today announces that it has signed a contract with Qingdao Zhong Jia Lian He Healthcare Management Company Limited to install a Proteus®PLUS* multi-room solution in Qingdao, Shandong Province, China. The contract is worth more than EUR 80 million to IBA, including a long term service contract.
IBA will equip the new center with five treatment rooms, four isocentric-gantry treatment rooms and a fixed-beam treatment room, including the latest generation of precision technologies in Adaptive Intensity Modulated Proton Therapy: Pencil Beam Scanning and Cone Beam CT. The contract includes an operations and maintenance agreement and will also provide all dosimetry equipment to ensure the safest and fastest commissioning of the center. Qingdao Zhong Jia Lian He Healthcare Management Company Limited expects to be treating patients at the center by the end of 2018.
Ad Statistics
Times Displayed: 49670
Times Visited: 1409 Ampronix, a Top Master Distributor for Sony Medical, provides Sales, Service & Exchanges for Sony Surgical Displays, Printers, & More. Rely on Us for Expert Support Tailored to Your Needs. Email info@ampronix.com or Call 949-273-8000 for Premier Pricing.
Olivier Legrain, Chief Executive Officer of IBA, commented: “This new collaboration with Qingdao Zhong Jia Lian He Healthcare Management Company Limited further strengthens IBA’s world leading position in proton therapy. The Proteus®PLUS proton therapy center in China will be one of the largest in the world, as well as being one of the most technically advanced, with the highest quality therapeutic and imaging capabilities. IBA is pleased to be playing an important role in bringing such innovative cancer treatment modalities to patients in China.”
Wang Xiang Yu, of Qingdao Zhong Jia Lian He Healthcare Management Company Limited said: “We want to have the most innovative treatments for our cancer patients in order to effectively fight this severe disease; proton therapy will help give our team of oncologists the critical tools to fight cancer. Our new Proteus®PLUS multi-room solution, including Pencil Beam Scanning and Cone Beam CT technology, will be installed by IBA and will allow us to ‘paint’ tumors with a super-fine beam of protons, destroying cancer cells whilst leaving surrounding healthy tissue untouched.”
